B.Braun Groupe in 2022 means :
- 8.5 billion euros in sales
- 66,000 employees
- 647 million euros in investments
- 64 countries
- 400 million euros in research and development activities
The Group's areas of expertise extend to hospital care with essential care devices, Aesculap with operating theatre equipment and implants, and Avitum with care associated with chronic diseases.
The Chaumont site specialises in Aesculap, which offers expertise in treatment, processes and service solutions for surgery, orthopaedics and vascular medicine.
Aesculap Chaumont designs and produces knee implants and associated instrumentation.
AESCULAP SAS - AB.BRAUN BRAND
